Nishant Shah warns that Meta's doing away with content moderation represents a dangerous lack of oversight. "A mix of human and algorithmic detection, flagging, scrutiny, resolution, and oversight has ...

Citigroup (C) and Evercore ISI are acting as book-running managers for the proposed IPO and as representatives of the underwriters. RBC Capital Markets and William Blair are acting as joint ...

In 2024, global and US markets saw a slight increase in IPOs. Syntax Data used its FIS classification system to analyze the ...

The tepid reception to Venture Global's ambitious valuation target shows companies need to set realistic expectations when ...

Nvidia remained above the 50-day moving average Friday. Late Tuesday, President Donald Trump announced a joint venture called ...

After what many considered a “slow” year for IPOs, January has ushered in a string of biotechs filing to go public. But 2024 ...

Some of the most high-profile names that are likely to headline this year's IPO market resurgence include Swedish payments ...

A global biopharma with a U.S. headquarters in Montgomery County is gearing up to go public on a U.S. exchange.

Odyssey Therapeutics is a promising biotech firm poised for IPO success with a focus on inflammatory and autoimmune diseases ...

The startups are the fourth and fifth drugmakers to file for initial stock sales since late December — the most IPO activity ...